Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
2.78Price to Book
VS
Market
Sector
Industry
History
$ 2.47Close
$ 1.31 - $ 5.74 52-Week Range
Ticker Information
Ticker
INOCompany Name
INOVIO PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINOVIO PHARMACEUTICALS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INO - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 28.53M | $ 79.18M | 2.78 |
| 3/31/2025 | $ 51.25M | $ 70.41M | 1.37 |
| 12/31/2024 | $ 68.5M | $ 77M | 1.12 |
| 9/30/2024 | $ 73.54M | $ 124.5M | 1.69 |
| 6/30/2024 | $ 96.74M | $ 226.15M | 2.34 |
| 3/31/2024 | $ 94.44M | $ 294.35M | 3.12 |
| 12/31/2023 | $ 117.35M | $ 230.67M | 1.97 |
| 9/30/2023 | $ 138.16M | $ 98.84M | 0.72 |
| 6/30/2023 | $ 169.37M | $ 108.28M | 0.64 |
| 3/31/2023 | $ 199.21M | $ 212.71M | 1.07 |
Key Performance Insights, Last 5 Years
- INOVIO PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/B stands at 4.45.
- Over the past 5 years, INOVIO PHARMACEUTICALS INC's average P/B has been 2.24.
- The median P/B for INOVIO PHARMACEUTICALS INC during this period was 1.86
- INOVIO PHARMACEUTICALS INC reached its highest P/B over the past 5 years at 5.22.
- The lowest P/B recorded by INOVIO PHARMACEUTICALS INC in the same timeframe 0.64
INOVIO PHARMACEUTICALS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for INOVIO PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 1.44B ] / Equity [ $ 323.9M ]
(=) P/B [ 4.45 ] INO - Price to Book, Last 5 years
0.64
Minimum
Jun 30, 2023
5.22
Maximum
Dec 31, 2020
2.24
Average
1.86
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |